Back to News
Market Impact: 0.35
Bausch + Lomb Swings To Profit In Q3, Lifts FY26 Guidance; Pre-market Shares Up
Source: Nasdaq
Corporate EarningsCorporate Guidance & OutlookHealthcare & BiotechCompany Fundamentals
Bausch + Lomb returned to profit in the third quarter of fiscal 2026, with revenue increasing across all three business segments. The company raised its full-year revenue and adjusted EBITDA guidance; the article provides no figures for the results or revised outlook.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.40
Ticker Sentiment
BLCO0.80
More News
- Bausch Health raises 2026 outlook as third-quarter adjusted earnings surge 53%
- BAUSCH HEALTH ANNOUNCES THIRD QUARTER 2026 RESULTS, RAISES GUIDANCE
- What investors need to know about Alphabet's stock-busting earnings report
- Our next steps for Alphabet stock after earnings disappoint at nearly every turn
- SK Hynix says the memory-chip shortage will last until 2030—and more than half its production is booked for the next two years
- China’s tech darlings are losing their shine. Here’s what’s behind the sell-off